The DRAGON 2 Trial

NARecruitingINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2029

Conditions
Colorectal Cancer Liver Metastases (CRLM)Small Future Liver Remnant (FLR)
Interventions
PROCEDURE

Embolization

Portal Vein embolization with Glue by a transhepatic approach vs. PVE and Hepatic Vein Occlusion with Vascular plugs via a transjugular or transfemoral approach in the same session as the PVE procedure

Trial Locations (24)

1070

RECRUITING

Hôpital Erasme, Brussels

1100

NOT_YET_RECRUITING

Social Medical Center, South, Vienna

3015

NOT_YET_RECRUITING

Erasmus Medical Center, Rotterdam

3168

RECRUITING

Monash Medical Centre, Clayton

4000

RECRUITING

CHU de Liège, Liège

5530

RECRUITING

CHU-UCL Namur site Godinne, Yvoir

8401

RECRUITING

Kantonsspital Winterthur (KSW), Winterthur

14186

RECRUITING

Karolinska University Hospital, Stockholm

06510

RECRUITING

Yale New Haven Hospital, New Haven

Gent (9000)

RECRUITING

UZ Gent, Ghent

V5Z 4H5

RECRUITING

Vancouver Coastal Health, Vancouver

ON L8V 5C2

RECRUITING

Juravinski Hospital and Cancer Centre, Hamilton

k1H 8L6

RECRUITING

The Ottawa Hospital, Ottawa

M4N 3M5

RECRUITING

Sunnybrook Hospital, Toronto

Unknown

NOT_YET_RECRUITING

McGill University Health Center, Montreal

RECRUITING

IRCCS San Raffaele Hospital, Milan

NOT_YET_RECRUITING

Amphia, Breda

RECRUITING

Maxima Medisch Centrum, Eindhoven

RECRUITING

Universitair Medisch Centrum Utrecht, Utrecht

6229 HX

RECRUITING

Maastricht University Medical Center+, Maastricht

1105 AZ

RECRUITING

Amsterdam UMC, location AMC, Amsterdam

9713 GZ

RECRUITING

University Medical Center Groningen, Groningen

581 85

RECRUITING

Linköping University Hospital, Linköping

CH-4058

RECRUITING

Claraspital & Clarunis University Hospital Basel, Basel

All Listed Sponsors
lead

Maastricht University

OTHER